183 related articles for article (PubMed ID: 36786072)
1. The protective effect of the mitochondrial-derived peptide MOTS-c on LPS-induced septic cardiomyopathy.
Wu J; Xiao D; Yu K; Shalamu K; He B; Zhang M
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):285-294. PubMed ID: 36786072
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of MOTS-c on acute lung injury induced by lipopolysaccharide in mice.
Xinqiang Y; Quan C; Yuanyuan J; Hanmei X
Int Immunopharmacol; 2020 Mar; 80():106174. PubMed ID: 31931370
[TBL] [Abstract][Full Text] [Related]
3. The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy.
Di S; Wang Z; Hu W; Yan X; Ma Z; Li X; Li W; Gao J
Front Endocrinol (Lausanne); 2020; 11():162. PubMed ID: 32373063
[No Abstract] [Full Text] [Related]
4. Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function.
Zhong J; Tan Y; Lu J; Liu J; Xiao X; Zhu P; Chen S; Zheng S; Chen Y; Hu Y; Guo Z
Redox Biol; 2019 Sep; 26():101287. PubMed ID: 31386965
[TBL] [Abstract][Full Text] [Related]
5. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway.
Zhang J; Wang L; Xie W; Hu S; Zhou H; Zhu P; Zhu H
J Cell Physiol; 2020 Mar; 235(3):2847-2856. PubMed ID: 31535369
[TBL] [Abstract][Full Text] [Related]
6. SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.
Xin T; Lu C
Aging (Albany NY); 2020 Jul; 12(16):16224-16237. PubMed ID: 32721927
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrocurcumin improves lipopolysaccharide-induced myocardial dysfunction by inhibiting oxidative stress and inflammation via JNK/ERK signaling pathway regulation.
Zhu H; Zhang L; Jia H; Xu L; Cao Y; Zhai M; Li K; Xia L; Jiang L; Li X; Zhou Y; Liu J; Yu S; Duan W
Phytomedicine; 2022 Sep; 104():154283. PubMed ID: 35779282
[TBL] [Abstract][Full Text] [Related]
8. The intraperitoneal administration of MOTS-c produces antinociceptive and anti-inflammatory effects through the activation of AMPK pathway in the mouse formalin test.
Yin X; Jing Y; Chen Q; Abbas AB; Hu J; Xu H
Eur J Pharmacol; 2020 Mar; 870():172909. PubMed ID: 31926126
[TBL] [Abstract][Full Text] [Related]
9. The DNA-dependent protein kinase catalytic subunit exacerbates endotoxemia-induced myocardial microvascular injury by disrupting the MOTS-c/JNK pathway and inducing profilin-mediated lamellipodia degradation.
Zou R; Shi W; Chang X; Zhang M; Tan S; Li R; Zhou H; Li Y; Wang G; Lv W; Fan X
Theranostics; 2024; 14(4):1561-1582. PubMed ID: 38389837
[No Abstract] [Full Text] [Related]
10. Interferon Regulatory Factor-2 Binding Protein 2 Ameliorates Sepsis-Induced Cardiomyopathy via AMPK-Mediated Anti-Inflammation and Anti-Apoptosis.
Li T; Luo Q; He L; Li D; Li Q; Wang C; Xie J; Yi C
Inflammation; 2020 Aug; 43(4):1464-1475. PubMed ID: 32239393
[TBL] [Abstract][Full Text] [Related]
11. Luteolin attenuates sepsis‑induced myocardial injury by enhancing autophagy in mice.
Wu B; Song H; Fan M; You F; Zhang L; Luo J; Li J; Wang L; Li C; Yuan M
Int J Mol Med; 2020 May; 45(5):1477-1487. PubMed ID: 32323750
[TBL] [Abstract][Full Text] [Related]
12. 1-Deoxynojirimycin attenuates septic cardiomyopathy by regulating oxidative stress, apoptosis, and inflammation via the JAK2/STAT6 signaling pathway.
Jiang L; Zhang L; Yang J; Shi H; Zhu H; Zhai M; Lu L; Wang X; Li XY; Yu S; Liu J; Duan W
Biomed Pharmacother; 2022 Nov; 155():113648. PubMed ID: 36108388
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-6 and IL-6/AMPK signaling pathway on mitochondrial biogenesis and astrocytes viability under experimental septic condition.
Chen XL; Wang Y; Peng WW; Zheng YJ; Zhang TN; Wang PJ; Huang JD; Zeng QY
Int Immunopharmacol; 2018 Jun; 59():287-294. PubMed ID: 29674256
[TBL] [Abstract][Full Text] [Related]
14. Sepsis-related myocardial injury is associated with Mst1 upregulation, mitochondrial dysfunction and the Drp1/F-actin signaling pathway.
Shang X; Li J; Yu R; Zhu P; Zhang Y; Xu J; Chen K; Li M
J Mol Histol; 2019 Apr; 50(2):91-103. PubMed ID: 30604255
[TBL] [Abstract][Full Text] [Related]
15. Irisin attenuates sepsis-induced cardiac dysfunction by attenuating inflammation-induced pyroptosis through a mitochondrial ubiquitin ligase-dependent mechanism.
Xiong X; Lu L; Wang Z; Ma J; Shao Y; Liu Y; Zhai M; Jin P; Yang J; Zheng Q; Liu J; Yang L
Biomed Pharmacother; 2022 Aug; 152():113199. PubMed ID: 35653888
[TBL] [Abstract][Full Text] [Related]
16. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.
Lu H; Wei M; Zhai Y; Li Q; Ye Z; Wang L; Luo W; Chen J; Lu Z
J Mol Med (Berl); 2019 Apr; 97(4):473-485. PubMed ID: 30725119
[TBL] [Abstract][Full Text] [Related]
17. NSC228155 alleviates septic cardiomyopathy via protecting mitochondria and inhibiting inflammation.
Jiang Y; Li Y; Zhang Y; Hu D; Zhang S; Wang C; Huang S; Zhang A; Jia Z; You R
Int Immunopharmacol; 2023 Mar; 116():109847. PubMed ID: 36774857
[TBL] [Abstract][Full Text] [Related]
18. MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model.
Wu N; Shen C; Wang J; Chen X; Zhong P
Cardiovasc Drugs Ther; 2023 Dec; ():. PubMed ID: 38141139
[TBL] [Abstract][Full Text] [Related]
19. Yap overexpression attenuates septic cardiomyopathy by inhibiting DRP1-related mitochondrial fission and activating the ERK signaling pathway.
Yu W; Mei X; Zhang Q; Zhang H; Zhang T; Zou C
J Recept Signal Transduct Res; 2019 Apr; 39(2):175-186. PubMed ID: 31354091
[No Abstract] [Full Text] [Related]
20. The Mitochondrial-Derived Peptide MOTS-c Attenuates Oxidative Stress Injury and the Inflammatory Response of H9c2 Cells Through the Nrf2/ARE and NF-κB Pathways.
Shen C; Wang J; Feng M; Peng J; Du X; Chu H; Chen X
Cardiovasc Eng Technol; 2022 Oct; 13(5):651-661. PubMed ID: 34859377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
